Free Trial

APG Asset Management N.V. Invests $25.23 Million in MetLife, Inc. (NYSE:MET)

MetLife logo with Finance background

APG Asset Management N.V. acquired a new position in MetLife, Inc. (NYSE:MET - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 319,100 shares of the financial services provider's stock, valued at approximately $25,232,000.

Other institutional investors have also recently made changes to their positions in the company. Sierra Ocean LLC bought a new position in shares of MetLife in the fourth quarter worth about $32,000. Retirement Wealth Solutions LLC bought a new position in MetLife in the 4th quarter worth approximately $32,000. Graney & King LLC purchased a new stake in MetLife during the 4th quarter valued at approximately $34,000. Values First Advisors Inc. bought a new stake in shares of MetLife during the fourth quarter valued at approximately $36,000. Finally, Bank Julius Baer & Co. Ltd Zurich purchased a new position in shares of MetLife in the fourth quarter worth $48,000. Institutional investors own 94.99% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on MET. Morgan Stanley reduced their price target on shares of MetLife from $109.00 to $94.00 and set an "overweight" rating on the stock in a report on Thursday, April 10th. Piper Sandler lifted their price objective on MetLife from $92.00 to $94.00 and gave the stock an "overweight" rating in a research note on Wednesday, April 2nd. Wells Fargo & Company cut their target price on shares of MetLife from $97.00 to $91.00 and set an "overweight" rating for the company in a report on Thursday, April 10th. JPMorgan Chase & Co. decreased their price target on shares of MetLife from $88.00 to $86.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 2nd. Finally, Keefe, Bruyette & Woods dropped their price objective on shares of MetLife from $98.00 to $95.00 and set an "outperform" rating for the company in a research note on Wednesday, April 9th. Two research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. Based on data from MarketBeat, MetLife presently has a consensus rating of "Moderate Buy" and an average target price of $92.46.

View Our Latest Research Report on MET

MetLife Trading Up 0.3 %

Shares of MET stock traded up $0.25 on Tuesday, reaching $73.20. 633,571 shares of the company's stock were exchanged, compared to its average volume of 3,391,336. The company's fifty day simple moving average is $80.08 and its 200 day simple moving average is $82.40. MetLife, Inc. has a 52 week low of $65.21 and a 52 week high of $89.05. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.54. The stock has a market capitalization of $49.87 billion, a PE ratio of 12.26, a P/E/G ratio of 0.65 and a beta of 0.89.

MetLife (NYSE:MET - Get Free Report) last released its earnings results on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share for the quarter, missing the consensus estimate of $2.13 by ($0.05). MetLife had a return on equity of 20.42% and a net margin of 6.19%. As a group, analysts forecast that MetLife, Inc. will post 9.65 EPS for the current year.

About MetLife

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

See Also

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Should You Invest $1,000 in MetLife Right Now?

Before you consider MetLife, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.

While MetLife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Tech Stocks to Buy Now—And 3 You’ll Regret Keeping
After Stellar Earnings, Is TSMC the Next Chip Leader?
Palantir’s Big Week Reveals a Rare Growth Story in a Shaky Market

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines